136 related articles for article (PubMed ID: 8619895)
1. Cytotoxic effects of a doxorubicin-transferrin conjugate in multidrug-resistant KB cells.
Fritzer M; Szekeres T; Szüts V; Jarayam HN; Goldenberg H
Biochem Pharmacol; 1996 Feb; 51(4):489-93. PubMed ID: 8619895
[TBL] [Abstract][Full Text] [Related]
2. Toxicity and DNA binding of dextran-doxorubicin conjugates in multidrug-resistant KB-V1 cells: optimization of dextran size.
Lam W; Leung CH; Chan HL; Fong WF
Anticancer Drugs; 2000 Jun; 11(5):377-84. PubMed ID: 10912954
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells.
Wang F; Jiang X; Yang DC; Elliott RL; Head JF
Anticancer Res; 2000; 20(2A):799-808. PubMed ID: 10810357
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-peptide conjugates overcome multidrug resistance.
Mazel M; Clair P; Rousselle C; Vidal P; Scherrmann JM; Mathieu D; Temsamani J
Anticancer Drugs; 2001 Feb; 12(2):107-16. PubMed ID: 11261883
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells.
Łubgan D; Jóźwiak Z; Grabenbauer GG; Distel LV
Cell Mol Biol Lett; 2009; 14(1):113-27. PubMed ID: 18850074
[TBL] [Abstract][Full Text] [Related]
6. Enhanced in vitro cytotoxicity of idarubicin compared to epirubicin and doxorubicin in rat prostate carcinoma cells.
Siegsmund MJ; Stendler A; Kreukler C; Köhrmann KU; Alken P
Eur Urol; 1997; 31(3):365-70. PubMed ID: 9129933
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of multidrug-resistant MCF-7 cells to a transferrin-doxorubicin conjugate.
Lemieux P; Pagé M
Anticancer Res; 1994; 14(2A):397-403. PubMed ID: 8017839
[TBL] [Abstract][Full Text] [Related]
8. Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells.
Rahman A; Husain SR; Siddiqui J; Verma M; Agresti M; Center M; Safa AR; Glazer RI
J Natl Cancer Inst; 1992 Dec; 84(24):1909-15. PubMed ID: 1361008
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistance.
Solary E; Ling YH; Perez-Soler R; Priebe W; Pommier Y
Int J Cancer; 1994 Jul; 58(1):85-94. PubMed ID: 8014019
[TBL] [Abstract][Full Text] [Related]
10. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.
Anuchapreeda S; Leechanachai P; Smith MM; Ambudkar SV; Limtrakul PN
Biochem Pharmacol; 2002 Aug; 64(4):573-82. PubMed ID: 12167476
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of P-glycoprotein mediated multidrug resistance by stemofoline derivatives.
Umsumarng S; Pintha K; Pitchakarn P; Sastraruji K; Sastraruji T; Ung AT; Jatisatienr A; Pyne SG; Limtrakul P
Chem Pharm Bull (Tokyo); 2013; 61(4):399-404. PubMed ID: 23358236
[TBL] [Abstract][Full Text] [Related]
12. Codelivery of Doxorubicin and Verapamil for Treating Multidrug Resistant Cancer Cells.
Williams JB; Buchanan CM; Pitt WG
Pharm Nanotechnol; 2018; 6(2):116-123. PubMed ID: 30207210
[TBL] [Abstract][Full Text] [Related]
13. Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells.
Szwed M; Matusiak A; Laroche-Clary A; Robert J; Marszalek I; Jozwiak Z
Toxicol In Vitro; 2014 Mar; 28(2):187-97. PubMed ID: 24055890
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance in cancer cells by pyranocoumarins isolated from Radix Peucedani.
Wu JY; Fong WF; Zhang JX; Leung CH; Kwong HL; Yang MS; Li D; Cheung HY
Eur J Pharmacol; 2003 Jul; 473(1):9-17. PubMed ID: 12877932
[TBL] [Abstract][Full Text] [Related]
15. Expression, subcellular distribution and response to phorbol esters of protein kinase C (PKC) isozymes in drug-sensitive and multidrug-resistant KB cells evidence for altered regulation of PKC-alpha.
Cloud-Heflin BA; McMasters RA; Osborn MT; Chambers TC
Eur J Biochem; 1996 Aug; 239(3):796-804. PubMed ID: 8774728
[TBL] [Abstract][Full Text] [Related]
16. Effects of lovastatin on a human myeloma cell line: increased sensitivity of a multidrug-resistant subline that expresses the 170 kDa P-glycoprotein.
Holmberg M; Sandberg C; Nygren P; Larsson R
Anticancer Drugs; 1994 Oct; 5(5):598-600. PubMed ID: 7858293
[TBL] [Abstract][Full Text] [Related]
17. Novel dithiane analogues of tiapamil with high activity to overcome multidrug resistance in vitro.
Eliason JF; Ramuz H; Yoshikubo T; Ishikawa T; Yamamoto T; Tsuruo T
Biochem Pharmacol; 1995 Jul; 50(2):187-96. PubMed ID: 7632162
[TBL] [Abstract][Full Text] [Related]
18. Association of 5' CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells.
Kusaba H; Nakayama M; Harada T; Nomoto M; Kohno K; Kuwano M; Wada M
Eur J Biochem; 1999 Jun; 262(3):924-32. PubMed ID: 10411657
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes.
Oudard S; Thierry A; Jorgensen TJ; Rahman A
Cancer Chemother Pharmacol; 1991; 28(4):259-65. PubMed ID: 1678995
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]